Cargando…
Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
A patient presented to clinic with atopic dermatitis that had been previously unresponsive to multiple topical and systemic therapies. They were successfully treated with a combination of tralokinumab and upadacitinib, showing significant improvement after 3 weeks and near-resolution after 6 months.
Autores principales: | Lansang, Rafael Paolo, Zhao, Irene X, Lansang, Perla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291146/ https://www.ncbi.nlm.nih.gov/pubmed/37377458 http://dx.doi.org/10.1177/2050313X231180766 |
Ejemplares similares
-
Upadacitinib for the treatment of alopecia areata and severe atopic dermatitis in a paediatric patient: A case report
por: Bourkas, Adrienn N, et al.
Publicado: (2022) -
IgA pemphigus following COVID-19 vaccination: A case report
por: Lansang, Rafael Paolo, et al.
Publicado: (2023) -
Upadacitinib-induced paradoxical face and scalp dermatitis: A case report of a novel sequela
por: Pastukhova, Elena, et al.
Publicado: (2023) -
Eosinophils in the skin—a red herring masking lymphoma: a case series
por: Jaque, Alejandra, et al.
Publicado: (2018) -
Psoriasis appearing after dupilumab therapy in atopic dermatitis: A case report
por: Kim, Ho Seung, et al.
Publicado: (2020)